Different sampling time points and Blinding [Bioanalytics]

posted by Pharma_88 – India, 2020-12-11 05:22 (44 d 08:00 ago) – Posting: # 22138
Views: 486

Dear all,

Please provide your suggestion for below concern.

for the bioequivalence studies, Analyst is always blind despite of regulatory requirement. By keeping different sampling time points i.e. 20 time-points for test and 22 time points for reference, whether analyst will blind in this condition?


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

Activity
 Admin contact
21,310 posts in 4,445 threads, 1,489 registered users;
online 5 (1 registered, 4 guests [including 3 identified bots]).
Forum time: Sunday 13:22 CET (Europe/Vienna)

Every man gets a narrower and narrower field of knowledge
in which he must be an expert in order to compete with other people.
The specialist knows more and more about less and less
and finally knows everything about nothing.    Konrad Lorenz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5